Table 2.
Item | CON+ | CSSO | p = |
---|---|---|---|
Pregnancy rates to AI (n = 11/treatment), % | 51.7 ± 4.1 | 60.2 ± 4.2 | 0.01 |
Physiological responses (n = 9/treatment) | |||
Endometrium, mRNA expression | |||
Cyclooxygenase-2 | 5.11 ± 1.32 | 4.88 ± 1.33 | 0.89 |
Prostaglandin E synthase | 7.40 ± 1.05 | 5.76 ± 1.15 | 0.30 |
Conceptus, mRNA expression | |||
Interferon-tau | 12.1 ± 3.6 | 21.3 ± 3.4 | 0.05 |
Prostaglandin E synthase | 2.50 ± 0.49 | 2.22 ± 0.48 | 0.69 |
Whole blood, mRNA expression | |||
Interferon-stimulated gene 15 | 29.8 ± 4.9 | 43.1 ± 4.3 | 0.04 |
Myxovirus resistance 2 | 20.1 ± 2.8 | 20.2 ± 2.5 | 0.98 |
20,50-oligoadenylate synthetase | 18.3 ± 2.9 | 26.8 ± 2.6 | 0.03 |
1 Conceptus and endometrial samples were collected on day 15 of gestation and whole blood was collected on day 20 of gestation, whereas pregnancy rates were diagnosed 28 days after AI.